LUNG Q2 2020 Earnings — Pulmonx Corporation Revenue & Financial Results | Market Cap Arena

LUNGPulmonx Corporation

$72M

Q2 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$4M-50.1% YoY

Gross Profit

$1M27.6% margin

Operating Income

-$12M-313.8% margin

Net Income

-$12M-324.3% margin

EPS (Diluted)

$-0.39

QoQ Revenue Growth

-57.4%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$8M

Stock-Based Comp.

$159,000

Balance Sheet

Total Assets

$67M

Total Liabilities

$272M

Stockholders' Equity

-$206M

Cash & Equivalents

$44M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$7M	-50.1%
Gross Profit	$1M	$5M	-79.6%
Operating Income	-$12M	-$5M	-137.4%
Net Income	-$12M	-$6M	-113.8%